These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3180146)

  • 1. Phase I study of recombinant human tumor necrosis factor (rHu-TNF:PT-050).
    Taguchi T
    Cancer Detect Prev; 1988; 12(1-6):561-72. PubMed ID: 3180146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A phase I study of recombinant human tumor necrosis factor (rHu-TNF: PT-050). The PT-050 Study Group].
    Taguchi T
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3491-7. PubMed ID: 3024581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human pharmacological investigation of a human recombinant tumor necrosis factor preparation (PAC-4D) a phase-I trial.
    Lenk H; Tanneberger S; Müller U; Shiga T
    Arch Geschwulstforsch; 1988; 58(2):89-97. PubMed ID: 3377652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I study of 24-hour continuous intravenous infusion of recombinant human tumor necrosis factor.
    Steinmetz T; Schaadt M; Gähl R; Schenk V; Diehl V; Pfreundschuh M
    J Biol Response Mod; 1988 Oct; 7(5):417-23. PubMed ID: 3183683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human TNF-alpha: preclinical studies and results from early clinical trials.
    Saks S; Rosenblum M
    Immunol Ser; 1992; 56():567-87. PubMed ID: 1550875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of recombinant human tumor necrosis factor in colorectal carcinoma.
    Schaadt M; Pfreundschuh M; Lorscheidt G; Peters KM; Steinmetz T; Diehl V
    J Biol Response Mod; 1990 Apr; 9(2):247-50. PubMed ID: 2341863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of recombinant human tumor necrosis factor alpha in rhesus monkeys after intravenous administration.
    Greischel A; Zahn G
    J Pharmacol Exp Ther; 1989 Oct; 251(1):358-61. PubMed ID: 2795465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of tumor necrosis factor alpha after intravenous administration in rats. Dose dependence and influence of tumor necrosis factor beta.
    Zahn G; Greischel A
    Arzneimittelforschung; 1989 Sep; 39(9):1180-2. PubMed ID: 2590273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recombinant human tumor necrosis factor alpha (TNF): preclinical studies and results of early clinical trials].
    Płuzańska A
    Acta Haematol Pol; 1994; 25(2 Suppl 1):148-54. PubMed ID: 8067200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General pharmacology of recombinant human tumor necrosis factor. 2nd communication: effects on central nervous system functions.
    Kurumiya S; Miura Y; Nakatsuji K; Dodo M; Hori M; Ito T
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):225-31. PubMed ID: 2334465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human tumor necrosis factor causes long-lasting and prostaglandin-mediated fever, with little tolerance, in rabbits.
    Nakamura H; Seto Y; Motoyoshi S; Kadokawa T; Sunahara N
    J Pharmacol Exp Ther; 1988 Apr; 245(1):336-41. PubMed ID: 3162987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible biological indicators of the response to recombinant tumour necrosis factor alpha in patients with advanced neoplasms.
    Braczkowski R; Zubelewicz B; Romanowski W; Lissoni P; Brivio F
    J Exp Clin Cancer Res; 1998 Sep; 17(3):349-54. PubMed ID: 9894774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I dose-escalation study of tumor necrosis factor-alpha and concomitant radiation therapy.
    Hallahan DE; Vokes EE; Rubin SJ; O'Brien S; Samuels B; Vijaykumar S; Kufe DW; Phillips R; Weichselbaum RR
    Cancer J Sci Am; 1995; 1(3):204-9. PubMed ID: 9166477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of vulva cancer responding to the recombinant human tumor necrosis factor (PT-950)--local injection therapy].
    Irie K; Satonaka K; Matsuura M; Miura Y; Nakayama H
    Gan No Rinsho; 1988 Jun; 34(7):946-50. PubMed ID: 3398264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies.
    Atkins MB; Robertson MJ; Gordon M; Lotze MT; DeCoste M; DuBois JS; Ritz J; Sandler AB; Edington HD; Garzone PD; Mier JW; Canning CM; Battiato L; Tahara H; Sherman ML
    Clin Cancer Res; 1997 Mar; 3(3):409-17. PubMed ID: 9815699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of intravenous treatment with tumor necrosis factor alpha in patients with advanced cancer--phase I clinical trials].
    Muc M; Baranowski M
    Przegl Lek; 1995; 52(10):496-8. PubMed ID: 8834840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local treatment of liver metastases with recombinant tumour necrosis factor (rTNF): a phase one study.
    IJzermans JN; van der Schelling GP; Scheringa M; Splinter TA; Marquet RL; Jeekel J
    Neth J Surg; 1991 Aug; 43(4):121-5. PubMed ID: 1944989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraperitoneal infusion of recombinant human tumor necrosis factor and mitoxantrone in neoplastic ascites: a feasibility study.
    Del Mastro L; Venturini M; Giannessi PG; Vigani A; Garrone O; Carnino F; Russo P; Galletti P; Rosso R; Conte PF
    Anticancer Res; 1995; 15(5B):2207-12. PubMed ID: 8572626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient increase of plasma interleukin-6 after infusion of recombinant tumor necrosis factor alpha in advanced cancer patients.
    Zubelewicz B; Romanowski W; Braczkowska B; Lissoni P; Braczkowski R
    J Exp Clin Cancer Res; 1998 Dec; 17(4):449-52. PubMed ID: 10089067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor in advanced gastrointestinal neoplasms. A clinical trial with a focus on haematological effects.
    Muc-Wierzgoń M; Baranowski M; Madej K
    Haematologia (Budap); 1996; 27(2):85-92. PubMed ID: 14651225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.